L'intérêt à découvert pour MariMed donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de MariMed. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

MariMed (OTC:MRMD) Stock, Rapport sur les intérêts à découvert

MariMed

MariMed Inc is a multi-state operator in the United States cannabis industry. It develops, operates, manages, and optimizes regulatory-compliant facilities for the cultivation, production, and dispensing of medical and adult-use cannabis. MariMed also licenses its proprietary brands of cannabis products along with other top brands in domestic markets Sources of revenue are comprised of Product sales (retail and wholesale), Real estate rental income, Supply procurement, Management fees and Licensing fees.

MariMed Inc

SEALSQ Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAES#NASDAQ">LAES</a>) shares are trading lower on Wednesday, reflecting a broader <a target="_blank" href="https://www.benzinga.com//node/42878295" rel="noreferrer noopener">decline in quantum computing stocks.</a>
This follows comments made by NVIDIA CEO Jensen Huang at an investor event on Tuesday, where he suggested that a fully functional quantum computer <a target="_blank" href="https://www.benzinga.com/tech/25/01/42879725/nvidia-ceo-sends-quantum-stocks-lower-poll-finds-over-50-pick-rigetti-or-skip-for-2025" rel="noreferrer noopener">could still be 15 to 30 years away.</a>
Huang&#8217;s cautionary statement has led to a more cautious sentiment around the quantum computing sector, which has seen significant investor enthusiasm in recent years, similar to the artificial intelligence boom.
Meanwhile, SEALSQ is making strides in another area: the <a target="_blank" href="https://www.benzinga.com//node/42872626" rel="noreferrer noopener">distribution of its secure chips.</a>
The company has launched its VaultIC secure microcontrollers and related development boards on DigiKey.
Also Read:<a target="_blank" href="https://www.benzinga.com/25/01/42878466/wildfire-rips-through-las-pacific-palisades-neighborhood-3000-acres-burned-30000-evacuated-homes-destroyed" rel="noreferrer noopener"> Wildfire Rips Through LA&#8217;s Pacific Palisades Neighborhood Destroying Homes: 3,000 Acres Burned As 30,000 Residents Evacuate</a>
DigiKey&#8217;s extensive platform reaches over 900,000 active customers worldwide across industries like automotive, healthcare, and consumer electronics.
This move will increase SEALSQ&#8217;s visibility and accessibility, providing engineers and designers with secure semiconductor solutions for their products.
Additionally, SEALSQ is advancing the development of its post-quantum Trusted Platform Module, slated for release in 2025.
The company&#8217;s partnership with DigiKey ensures a streamlined route for these quantum-resistant solutions to reach the market, reinforcing SEALSQ&#8217;s commitment to future-proof security.
Franck Buonnanno, SEALSQ&#8217;s VP of Sales, emphasized that this partnership marks just the beginning, with plans for further product offerings, including next-generation secure microcontrollers.
Price Action: LAES shares are trading lower by 40% to $4.288 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/12/42638753/quantum-computing-the-new-ai-a-look-at-the-rapidly-expanding-market-and-top-stocks-for-2025" target="_blank" rel="noreferrer noopener">Quantum Computing: The New AI? A Look at the Rapidly Expanding Market and Top Stocks For 2025</a></li>
</ul>
Image via Shutterstock.

Equities

News

Markets

General

LAES

SEALSQ Expands Reach With DigiKey Launch: Details

Lake Street analyst Mark Smith initiates coverage on Strawberry Fields REIT (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/STRW#AMEX">STRW</a>) with a Buy rating and announces Price Target of $13.5.

Price Target

Initiation

Analyst Ratings

STRW

Lake Street Initiates Coverage On Strawberry Fields REIT with Buy Rating, Announces Price Target of $13.5

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Below are some instances of options activity happening in the Health Care sector: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>JNJ</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$142.00</td>
<td>$132.6K</td>
<td>236</td>
<td>1.1K</td>
</tr>
<tr>
<td>CAPR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$15.00</td>
<td>$35.0K</td>
<td>3.7K</td>
<td>750</td>
</tr>
<tr>
<td>SOLV</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$70.00</td>
<td>$25.0K</td>
<td>711</td>
<td>608</td>
</tr>
<tr>
<td>GEHC</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$92.50</td>
<td>$83.4K</td>
<td>14</td>
<td>340</td>
</tr>
<tr>
<td>ABBV</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$210.00</td>
<td>$87.3K</td>
<td>2.5K</td>
<td>284</td>
</tr>
<tr>
<td>CVS</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$45.00</td>
<td>$28.6K</td>
<td>53.7K</td>
<td>193</td>
</tr>
<tr>
<td>ABT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$110.00</td>
<td>$106.5K</td>
<td>210</td>
<td>101</td>
</tr>
<tr>
<td>VEEV</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$220.00</td>
<td>$64.2K</td>
<td>184</td>
<td>20</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding JNJ (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>), we observe a put option trade with neutral sentiment. It expires in 9 day(s) on January 17, 2025. Parties traded 829 contract(s) at a $142.00 strike. The total cost received by the writing party (or parties) was $132.6K, with a price of $160.0 per contract. There were 236 open contracts at this strike prior to today, and today 1103 contract(s) were bought and sold. 
• For CAPR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAPR#NASDAQ">CAPR</a>), we notice a put option sweep that happens to be bearish, expiring in 9 day(s) on January 17, 2025. This event was a transfer of 250 contract(s) at a $15.00 strike. This particular put needed to be split into 25 different trades to become filled. The total cost received by the writing party (or parties) was $35.0K, with a price of $140.0 per contract. There were 3727 open contracts at this strike prior to today, and today 750 contract(s) were bought and sold. 
• Regarding SOLV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOLV#NYSE">SOLV</a>), we observe a call option trade with bullish sentiment. It expires in 9 day(s) on January 17, 2025. Parties traded 100 contract(s) at a $70.00 strike. The total cost received by the writing party (or parties) was $25.0K, with a price of $250.0 per contract. There were 711 open contracts at this strike prior to today, and today 608 contract(s) were bought and sold. 
• For GEHC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEHC#NASDAQ">GEHC</a>), we notice a call option sweep that happens to be bearish, expiring in 254 day(s) on September 19, 2025. This event was a transfer of 139 contract(s) at a $92.50 strike. This particular call needed to be split into 18 different trades to become filled. The total cost received by the writing party (or parties) was $83.4K, with a price of $600.0 per contract. There were 14 open contracts at this strike prior to today, and today 340 contract(s) were bought and sold. 
• Regarding ABBV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>), we observe a call option sweep with bullish sentiment. It expires in 373 day(s) on January 16, 2026. Parties traded 148 contract(s) at a $210.00 strike. This particular call needed to be split into 19 different trades to become filled. The total cost received by the writing party (or parties) was $87.3K, with a price of $590.0 per contract. There were 2546 open contracts at this strike prior to today, and today 284 contract(s) were bought and sold. 
• For CVS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>), we notice a put option trade that happens to be bullish, expiring in 44 day(s) on February 21, 2025. This event was a transfer of 100 contract(s) at a $45.00 strike. The total cost received by the writing party (or parties) was $28.6K, with a price of $286.0 per contract. There were 53788 open contracts at this strike prior to today, and today 193 contract(s) were bought and sold. 
• Regarding ABT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>), we observe a call option sweep with bearish sentiment. It expires in 254 day(s) on September 19, 2025. Parties traded 101 contract(s) at a $110.00 strike. This particular call needed to be split into 11 different trades to become filled. The total cost received by the writing party (or parties) was $106.5K, with a price of $1055.0 per contract. There were 210 open contracts at this strike prior to today, and today 101 contract(s) were bought and sold. 
• For VEEV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VEEV#NYSE">VEEV</a>), we notice a call option trade that happens to be neutral, expiring in 373 day(s) on January 16, 2026. This event was a transfer of 20 contract(s) at a $220.00 strike. The total cost received by the writing party (or parties) was $64.2K, with a price of $3210.0 per contract. There were 184 open contracts at this strike prior to today, and today 20 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more news on unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Options

ABBV

CAPR

GEHC

SOLV

VEEV

8 Health Care Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders often look for circumstances when the market estimation of an option diverges away from its normal worth. Abnormal amounts of trading activity could push option prices to hyperbolic or underperforming levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/10/25</td>
<td>$400.00</td>
<td>$31.6K</td>
<td>14.3K</td>
<td>55.6K</td>
</tr>
<tr>
<td>GME</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$30.00</td>
<td>$29.6K</td>
<td>28.6K</td>
<td>1.2K</td>
</tr>
<tr>
<td>AMZN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$230.00</td>
<td>$31.9K</td>
<td>19.4K</td>
<td>1.2K</td>
</tr>
<tr>
<td>PDD</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$70.00</td>
<td>$38.4K</td>
<td>1.2K</td>
<td>536</td>
</tr>
<tr>
<td>ETSY</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$50.00</td>
<td>$199.2K</td>
<td>1.1K</td>
<td>401</td>
</tr>
<tr>
<td>BABA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$75.00</td>
<td>$50.1K</td>
<td>1.1K</td>
<td>23</td>
</tr>
<tr>
<td>BKNG</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$4550.00</td>
<td>$30.0K</td>
<td>484</td>
<td>9</td>
</tr>
<tr>
<td>MELI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$1920.00</td>
<td>$32.2K</td>
<td>113</td>
<td>2</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These itemized elaborations have been created using the accompanying table. 
• Regarding TSLA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>), we observe a call option sweep with bearish sentiment. It expires in 2 day(s) on January 10, 2025. Parties traded 79 contract(s) at a $400.00 strike. This particular call needed to be split into 75 different trades to become filled. The total cost received by the writing party (or parties) was $31.6K, with a price of $400.0 per contract. There were 14336 open contracts at this strike prior to today, and today 55678 contract(s) were bought and sold. 
• Regarding GME (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>), we observe a call option sweep with bearish sentiment. It expires in 9 day(s) on January 17, 2025. Parties traded 79 contract(s) at a $30.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $29.6K, with a price of $375.0 per contract. There were 28618 open contracts at this strike prior to today, and today 1248 contract(s) were bought and sold. 
• Regarding AMZN (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), we observe a call option sweep with bearish sentiment. It expires in 44 day(s) on February 21, 2025. Parties traded 42 contract(s) at a $230.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $31.9K, with a price of $760.0 per contract. There were 19403 open contracts at this strike prior to today, and today 1204 contract(s) were bought and sold. 
• Regarding PDD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>), we observe a put option sweep with bearish sentiment. It expires in 99 day(s) on April 17, 2025. Parties traded 534 contract(s) at a $70.00 strike. This particular put needed to be split into 35 different trades to become filled. The total cost received by the writing party (or parties) was $38.4K, with a price of $72.0 per contract. There were 1263 open contracts at this strike prior to today, and today 536 contract(s) were bought and sold. 
• Regarding ETSY (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ETSY#NASDAQ">ETSY</a>), we observe a call option sweep with bullish sentiment. It expires in 163 day(s) on June 20, 2025. Parties traded 240 contract(s) at a $50.00 strike. This particular call needed to be split into 3 different trades to become filled. The total cost received by the writing party (or parties) was $199.2K, with a price of $830.0 per contract. There were 1162 open contracts at this strike prior to today, and today 401 contract(s) were bought and sold. 
• For BABA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>), we notice a call option trade that happens to be bearish, expiring in 737 day(s) on January 15, 2027. This event was a transfer of 21 contract(s) at a $75.00 strike. The total cost received by the writing party (or parties) was $50.1K, with a price of $2390.0 per contract. There were 1182 open contracts at this strike prior to today, and today 23 contract(s) were bought and sold. 
• Regarding BKNG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>), we observe a call option trade with bearish sentiment. It expires in 9 day(s) on January 17, 2025. Parties traded 1 contract(s) at a $4550.00 strike. The total cost received by the writing party (or parties) was $30.0K, with a price of $30000.0 per contract. There were 484 open contracts at this strike prior to today, and today 9 contract(s) were bought and sold. 
• For MELI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>), we notice a put option trade that happens to be bearish, expiring in 373 day(s) on January 16, 2026. This event was a transfer of 1 contract(s) at a $1920.00 strike. The total cost received by the writing party (or parties) was $32.2K, with a price of $32280.0 per contract. There were 113 open contracts at this strike prior to today, and today 2 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMZN

BABA

BKNG

ETSY

MELI

Citigourp Global Markets 2% Protected Notes Linked To The Djia

TSLA

8 Consumer Discretionary Stocks Whale Activity In Today's Session

This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth. High amounts of trading activity could push option prices to exaggerated or underestimated levels. 
Here's the list of options activity happening in today's session: 
<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVDA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/10/25</td>
<td>$145.00</td>
<td>$26.7K</td>
<td>58.9K</td>
<td>139.7K</td>
</tr>
<tr>
<td>AAPL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/10/25</td>
<td>$242.50</td>
<td>$25.5K</td>
<td>10.0K</td>
<td>17.8K</td>
</tr>
<tr>
<td>MSTR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/10/25</td>
<td>$300.00</td>
<td>$25.2K</td>
<td>7.3K</td>
<td>8.0K</td>
</tr>
<tr>
<td>RGTI</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$7.50</td>
<td>$64.6K</td>
<td>3.0K</td>
<td>3.7K</td>
</tr>
<tr>
<td>QBTS</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>02/21/25</td>
<td>$11.00</td>
<td>$27.1K</td>
<td>3.0K</td>
<td>1.5K</td>
</tr>
<tr>
<td>CSCO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/14/25</td>
<td>$62.00</td>
<td>$48.4K</td>
<td>66</td>
<td>1.5K</td>
</tr>
<tr>
<td>MARA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$17.00</td>
<td>$54.2K</td>
<td>1.7K</td>
<td>1.4K</td>
</tr>
<tr>
<td>AMD</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$100.00</td>
<td>$959.0K</td>
<td>7.5K</td>
<td>1.4K</td>
</tr>
<tr>
<td>PLTR</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$60.00</td>
<td>$52.1K</td>
<td>4.1K</td>
<td>1.1K</td>
</tr>
<tr>
<td>APP</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/24/25</td>
<td>$275.00</td>
<td>$219.7K</td>
<td>92</td>
<td>607</td>
</tr>
</tbody>
</table>

<h2>Explanation</h2>
These bullet-by-bullet explanations have been constructed using the accompanying table. 
• Regarding NVDA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), we observe a call option sweep with bearish sentiment. It expires in 2 day(s) on January 10, 2025. Parties traded 973 contract(s) at a $145.00 strike. This particular call needed to be split into 4 different trades to become filled. The total cost received by the writing party (or parties) was $26.7K, with a price of $27.0 per contract. There were 58940 open contracts at this strike prior to today, and today 139712 contract(s) were bought and sold. 
• For AAPL (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), we notice a put option trade that happens to be bearish, expiring in 2 day(s) on January 10, 2025. This event was a transfer of 150 contract(s) at a $242.50 strike. The total cost received by the writing party (or parties) was $25.5K, with a price of $170.0 per contract. There were 10047 open contracts at this strike prior to today, and today 17846 contract(s) were bought and sold. 
• For MSTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), we notice a put option sweep that happens to be bearish, expiring in 2 day(s) on January 10, 2025. This event was a transfer of 75 contract(s) at a $300.00 strike. This particular put needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $25.2K, with a price of $338.0 per contract. There were 7331 open contracts at this strike prior to today, and today 8046 contract(s) were bought and sold. 
• For RGTI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>), we notice a put option trade that happens to be bearish, expiring in 44 day(s) on February 21, 2025. This event was a transfer of 497 contract(s) at a $7.50 strike. The total cost received by the writing party (or parties) was $64.6K, with a price of $130.0 per contract. There were 3017 open contracts at this strike prior to today, and today 3756 contract(s) were bought and sold. 
• For QBTS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NYSE">QBTS</a>), we notice a put option sweep that happens to be bullish, expiring in 44 day(s) on February 21, 2025. This event was a transfer of 46 contract(s) at a $11.00 strike. This particular put needed to be split into 6 different trades to become filled. The total cost received by the writing party (or parties) was $27.1K, with a price of $591.0 per contract. There were 3005 open contracts at this strike prior to today, and today 1577 contract(s) were bought and sold. 
• Regarding CSCO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>), we observe a call option sweep with bearish sentiment. It expires in 37 day(s) on February 14, 2025. Parties traded 683 contract(s) at a $62.00 strike. This particular call needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $48.4K, with a price of $71.0 per contract. There were 66 open contracts at this strike prior to today, and today 1553 contract(s) were bought and sold. 
• Regarding MARA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>), we observe a put option sweep with bearish sentiment. It expires in 9 day(s) on January 17, 2025. Parties traded 950 contract(s) at a $17.00 strike. This particular put needed to be split into 27 different trades to become filled. The total cost received by the writing party (or parties) was $54.2K, with a price of $57.0 per contract. There were 1722 open contracts at this strike prior to today, and today 1424 contract(s) were bought and sold. 
• Regarding AMD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMD#NASDAQ">AMD</a>), we observe a put option trade with bullish sentiment. It expires in 254 day(s) on September 19, 2025. Parties traded 1400 contract(s) at a $100.00 strike. The total cost received by the writing party (or parties) was $959.0K, with a price of $685.0 per contract. There were 7520 open contracts at this strike prior to today, and today 1403 contract(s) were bought and sold. 
• For PLTR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>), we notice a put option sweep that happens to be neutral, expiring in 163 day(s) on June 20, 2025. This event was a transfer of 70 contract(s) at a $60.00 strike. This particular put needed to be split into 5 different trades to become filled. The total cost received by the writing party (or parties) was $52.1K, with a price of $745.0 per contract. There were 4182 open contracts at this strike prior to today, and today 1112 contract(s) were bought and sold. 
• For APP (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>), we notice a put option sweep that happens to be bearish, expiring in 16 day(s) on January 24, 2025. This event was a transfer of 594 contract(s) at a $275.00 strike. This particular put needed to be split into 38 different trades to become filled. The total cost received by the writing party (or parties) was $219.7K, with a price of $370.0 per contract. There were 92 open contracts at this strike prior to today, and today 607 contract(s) were bought and sold. 
Options Alert Terminology 
 - Call Contracts: The right to buy shares as indicated in the contract. 
 - Put Contracts: The right to sell shares as indicated in the contract. 
 - Expiration Date: When the contract expires. One must act on the contract by this date if one wants to use it. 
 - Premium/Option Price: The price of the contract. 
For more information, visit our <a href="https://pro.benzinga.com/blog/how-to-understand-option-alerts/">Guide to Understanding Options Alerts</a> or read <a href="https://www.benzinga.com/markets/options">more about unusual options activity</a>. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AAPL

CSCO

MARA

MSTR

NVDA

PLTR

QBTS

RGTI

10 Information Technology Stocks With Whale Alerts In Today's Session

TD Cowen analyst Vivien Azer upgrades Coca-Cola (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) from Hold to Buy and announces $75 price target.

Upgrades

TD Cowen Upgrades Coca-Cola to Buy, Announces $75 Price Target

WIIM

Constellation Energy shares are trading lower following a Bloomberg report indicating the company is nearing a $30 billion deal for Calpine.

On Tuesday, Verizon Communications Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>) &nbsp;announced that its <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42846640/verizon-shatters-speed-barriers-with-5-5-gbps-breakthrough" rel="noreferrer noopener">engineers achieved</a> 5.5 Gbps download speeds in mobile technology using carrier aggregation and Verizon&#8217;s 5G virtualized technology.
The company said the download speed is equivalent to downloading 266 Taylor Swift albums a minute or streaming 3,056 Hulu episodes per hour.
Verizon, Samsung Electronics (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SSNLF#OTC">SSNLF</a>), and MediaTek demonstrated 5G speeds of 5.5 gigabits per second in a 5G lab environment.
Also Read: <a target="_blank" href="https://www.benzinga.com/media/24/12/42727432/att-and-verizon-contain-cyberattack-linked-to-chinas-salt-typhoon-group" rel="noreferrer noopener">AT&amp;T and Verizon Contain Cyberattack Linked to China&#8217;s Salt Typhoon Group</a>
Verizon scored another win on Tuesday. The U.S. Air Force (USAF) has selected Verizon Business <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/g42844283/verizon-selected-by-the-u-s-air-force-for-5g-and-network-upgrades-at-35-installations" rel="noreferrer noopener">to install 5G</a> and 4G LTE network enhancements on 35 Air Force installations nationwide.
Verizon Business will deliver network enhancements such as C-Band carrier additions through the Air Force&#8217;s Offer to Lease (OTL) program.
Verizon&#8217;s network solutions will bring higher speeds, increased bandwidth, and lower latency for base personnel and the surrounding community.
Verizon and its peer internet service providers got a boost from the court&#8217;s overruling of <a target="_blank" href="https://www.benzinga.com/government/regulations/25/01/42798568/the-death-of-net-neutrality-winners-losers-and-what-it-means-for-the-future-of-the-interne" rel="noreferrer noopener">net neutrality that</a> will help them&nbsp;explore tiered pricing models, prioritize traffic, and charge content providers for faster delivery.
Verizon stock has lost 4% in the last 12 months. In October,&nbsp;Keybanc&#8216;s&nbsp;Brandon Nispel&nbsp;<a target="_blank" href="https://www.benzinga.com/tech/24/12/42536593/verizon-teams-up-with-nvidia-to-power-ai-apps-over-private-5g-networks" rel="noreferrer noopener">downgraded&nbsp;Verizon&#8217;s&nbsp;rating </a>after&nbsp;the company&#8217;s lackluster&nbsp;quarterly results.
In December, Verizon and Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) launched an AI-powered private 5G solution that supports AI, AR/VR, robotics, IoT, <a target="_blank" href="https://www.benzinga.com/tech/24/12/42536593/verizon-teams-up-with-nvidia-to-power-ai-apps-over-private-5g-networks" rel="noreferrer noopener">and streaming services</a>.
Price action:&nbsp;VZ stock is down 0.60% at $38.69 at the last check on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/quote/VZ" target="_blank" rel="noreferrer noopener">Tencent Strengthens Video Leadership, Showcases Revenue Growth Potential: Analyst</a></li>
</ul>
Photo by JHVE via Shutterstock

Government

Regulations

Tech

SSNLF

Verizon Hits 5.5 Gbps 5G Speeds, Lands Air Force Deal to Upgrade Base Networks Nationwide

Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CPRX#NASDAQ">CPRX</a>), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that the Company and its licensor SERB S.A. ("SERB") have entered into a Settlement Agreement (Agreement) with Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc. (collectively Teva). This Agreement resolves the patent litigation brought by Catalyst and SERB in response to Teva's Abbreviated New Drug Application (ANDA) seeking approval to market a generic version of FIRDAPSE&#xAE; (amifampridine) 10 mg tablets prior to expiration of the applicable patents.
Pursuant to the terms of the Agreement, Teva will not market its generic version of FIRDAPSE in the United States any earlier than February 25, 2035, if approved by the U.S. Food and Drug Administration (FDA), unless certain limited circumstances customarily included in these types of agreements occur. In accordance with the Agreement, the parties will terminate all ongoing patent litigation between Catalyst/SERB and Teva regarding FIRDAPSE patents pending in the U.S. District Court for the District of New Jersey. The pending FIRDAPSE patent litigation against the remaining defendants, Hetero (for all of FIRDAPSE's Orange Book-listed patents) and Lupin (only for Catalyst's FIRDAPSE patent expiring in 2037), is ongoing.
As required by law, the companies will submit the confidential license agreement to the U.S. Federal Trade Commission and the U.S. Department of Justice for review.
 &nbsp;

Contracts

Legal

CPRX

TEVA

Catalyst Pharmaceuticals Announces Settlement Of FIRDAPSE Patent Litigation With Teva Pharmaceuticals; Teva Will Not Market Its Generic Version Of FIRDAPSE In The U.S. Any Earlier Than February 25, 2035, If Approved By The FDA

<a href="https://www.bloomberg.com/news/articles/2025-01-08/constellation-energy-nears-30-billion-deal-for-calpine?utm_campaign=socialflow-organic&amp;utm_source=twitter&amp;utm_medium=social&amp;cmpid=socialflow-twitter-business&amp;utm_content=business&amp;sref=y3YMCJ4e" title="https://www.bloomberg.com/news/articles/2025-01-08/constellation-energy-nears-30-billion-deal-for-calpine?utm_campaign=socialflow-organic&amp;utm_source=twitter&amp;utm_medium=social&amp;cmpid=socialflow-twitter-business&amp;utm_content=business&amp;sref=y3YMCJ4e">https://www.bloomberg.com/news/articles/2025-01-08/constellation-energy-nears-30-billion-deal-for-calpine?utm_campaign=socialflow-organic&amp;utm_source=twitter&amp;utm_medium=social&amp;cmpid=socialflow-twitter-business&amp;utm_content=business&amp;sref=y3YMCJ4e</a>
&nbsp;
Constellation Energy Corp. is nearing an acquisition of Calpine Corp., people familiar with the matter said, in what would be one of the biggest ever deals in the power generation sector.

'Constellation Energy Nears $30B Deal For Calpine' - Bloomberg News

TD Cowen analyst Robert Moskow upgrades McCormick &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) from Hold to Buy and raises the price target from $86 to $90.

TD Cowen Upgrades McCormick & Co to Buy, Raises Price Target to $90

Growth in Phreesia Inc&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHR#NYSE">PHR</a>) <a href="https://www.benzinga.com/general/health-care">average revenue per client</a> is poised to accelerate, according to RBC Capital Markets.
The Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/591ed97d290fa70001e6c69b/sean-dodge">Analyst Sean Dodge</a> upgraded the rating for Phreesia from Sector Perform to Outperform. He also raised the price target from $24 to $32.
The Thesis: Historically, new client additions drove Phreesia's growth. The healthcare tech company has "recently realigned its efforts" to focus on monetizing its existing client base, Dodge said in an upgrade note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Phreesia's efforts are directed towards an increasingly larger proportion of growth being driven by existing clients, he added.
The company's average revenue per client remained almost flat for two years, the analyst stated. 
Throughout the fiscal third quarter, it grew by 3% year-on-year.
This metric could accelerate, he further stated. Why? The company&#8217;s Network Solutions is gaining momentum. 
Phreesia also benefits from "the cross-selling of several of its newer (but seasoned) provider add-ons." The company also signed new clients with "bigger initial solution bundles.&#8221; 
PHR Price Action: Shares of Phreesia had risen by 3.3% to $27.84 at the time of publication on Wednesday.
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/10/41626748/global-payments-revenue-eps-come-in-below-q3-estimates-francisco-partners-to-acquire-advancedmd-bus">Global Payments Revenue, EPS Come In Below Q3 Estimates, Francisco Partners To Acquire AdvancedMD Business</a></li>
</ul>
Image: Shutterstock

Health Care

Here's Why Phreesia's Average Revenue Per Client Will Accelerate: Analyst

Donald Trump's ambitious immigration enforcement plans face operational <a href="https://www.benzinga.com/startups/24/11/41722059/trumps-deportation-plan-faces-criticism-as-taxpayers-shoulder-the-billions-while-big-business-stands">and financial hurdles</a> that could take years to overcome.
The immigration court backlog, currently scheduling cases as far as 2029, is just one of the obstacles, according to a report issued by the Wall Street Journal last week. With only 500 immigration judges in the system, experts estimate that an additional 5,000 judges would need to be hired to efficiently process existing and new cases – a massive staffing challenge requiring substantial congressional funding.
U.S. Immigration and Customs Enforcement (ICE) faces similar resource constraints. The agency currently operates with about 6,000 agents and has a detention capacity for 40,000 immigrants. <a href="https://www.benzinga.com/news/24/12/42715951/trump-backs-immigration-visas-musk-praises-his-stance-and-says-rising-tide-lifts-all-boats">Trump&#8217;s </a>designated border czar, Tom Homan told the Wall Street Journal that military resources could potentially support deportation efforts, though military personnel would be restricted to ancillary tasks like transportation.
Don't Miss:
<ul>
<li>It&#8217;s no wonder Jeff Bezos holds over $70 million in art — <a href="https://www.benzinga.com/money/masterworks">this alternative asset has outpaced the S&amp;P 500 since 1995, delivering an average annual return of 11.4%. Here&#8217;s how everyday investors are getting started.</a></li>
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a></li>
</ul>
Democratic-led cities present another challenge to implementing widespread deportations. Chicago Mayor Brandon Johnson recently told CNN that he would not cooperate with federal immigration authorities, saying, &#8220;The law is very clear. Local police officers are not federal agents.&#8221;&nbsp;
Denver Mayor Mike Johnston, while supporting limited deportations of violent offenders, has publicly opposed mass deportations and indicated a willingness to face arrest in resistance.
Modern <a href="https://www.benzinga.com/news/24/09/40744471/trumps-plan-to-ban-mortgages-for-undocumented-immigrants-sparks-debate-what-do-the-numbers-say">immigration </a>patterns further complicate deportation logistics, the WSJ said. Unlike the Eisenhower-era deportations Trump often references, which primarily involved Mexican nationals, today&#8217;s immigrants arrive from nations including China, India, Mauritania, and Uzbekistan.&nbsp;
See Also: <a href="https://www.benzinga.com/money/qnetic-2">This 12,000 RPM Spinning Battery With Over $100 Million In LOIs Could Be The Missing Link For Green Energy — Here&#8217;s Why Early Investors Are Flocking To Invest Before Funding Closes</a>
It requires coordination with multiple foreign governments, many of which have strained diplomatic relations with the U.S.
Legal barriers also pose challenges. Many proposed changes would require congressional action or even constitutional amendments. The birthright citizenship reform Trump advocates would likely necessitate amending the Constitution – a process last completed in 1992, more than two centuries after that amendment&#8217;s initial proposal.
Trump&#8217;s advisers, including incoming deputy chief of staff Stephen Miller, have suggested pursuing policies that may face legal challenges to test their limits before the conservative-majority Supreme Court. However, existing laws guarantee certain rights, like asylum applications, regardless of entry method.
Trending: The global games market is projected to generate $272B by the end of the year —<a href="https://www.benzinga.com/money/gameflip"> for $0.55/share, this VC-backed startup with a 7M+ userbase gives investors easy access to this asset market.</a>
The implementation timeline for any major immigration enforcement changes would stretch well beyond initial executive actions. Even with successful funding through budget reconciliation, the government would require time to recruit and train new ICE officers and expand detention facilities.
Without local cooperation from sanctuary cities, ICE operations become much more complex. The agency would need to dedicate additional resources to surveillance and enforcement, as sanctuary policies restrict information sharing about immigrant releases from local jails.
Read Next:
<ul>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.26/share with a $1000 minimum.</a></li>
<li>If there was a new fund backed by Jeff Bezos offering a <a href="https://www.benzinga.com/money/arrived-private-credit-fund">7-9% target yield with monthly dividends would you invest in it</a>?</li>
</ul>

Startups

Trump's Immigration Plan Faces Multi-Billion-Dollar Hurdles And Delays According to WSJ

Solventum shares are trading higher after Nelson Peltz reportedly sent a letter to shareholders.

On Wednesday, Vir Biotechnology, Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VIR#NASDAQ">VIR</a>) stock traded higher after the company presented initial Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets a variety of HER2-expressing solid tumors, and VIR-5500, which targets PSMA in metastatic castration-resistant <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42871000/vir-biotechnology-announces-encouraging-safety-and-efficacy-data-in-ongoing-dose-escalation-trials" rel="noreferrer noopener">prostate cancer (mCRPC)</a>.
Data show encouraging preliminary safety and efficacy profiles with no dose-limiting cytokine release syndrome (CRS), maximum tolerated dose (MTD) not yet reached as dose escalation continues, and early clinical response signals observed in heavily pretreated participants.
These initial results provide clinical support for Vir Biotechnology&#8217;s in-licensed PRO-XTEN masking technology, designed to enable the selective activation of TCEs in the tumor microenvironment, mitigating damage to healthy cells and reducing toxicity.
VIR-5818:&nbsp;PRO-XTEN Initial Proof-of-Concept and Potential First-in-Class HER2 Immunotherapy
<ul>
<li>Early efficacy data indicate that 50% (10/20) of participants receiving VIR-5818 doses ≥400 µg/kg experienced dose-dependent tumor shrinkage across multiple HER2-positive tumor types.</li>
<li>Strong anti-tumor activity was observed in a subset of participants with HER2-positive CRC who have exhausted standard of care. In this subset, confirmed partial responses (cPRs) were seen in 33% (2/6) of participants at early doses, and one patient continued in cPR for more than 18 months as of the data cut-off.</li>
<li>Preliminary safety data demonstrate that VIR-5818 is generally well-tolerated, with minimal grade 1 or 2 CRS.</li>
</ul>
VIR-5500: First Dual-Masked PSMA-Targeting TCE
<ul>
<li>Early efficacy data show encouraging signs of prostate-specific antigen (PSA) responses, and PSA reductions were observed in 100% (12/12) of participants after an initial dose ≥120 µg/kg. PSA50 response was confirmed in 58% (7/12) of participants receiving a first dose ≥120 µg/kg.</li>
<li>Preliminary data show a promising safety profile, with no dose-limiting toxicities observed up to 1000 µg/kg without prophylactic corticosteroids.</li>
</ul>
In November, Vir Biotechnology announced end-of-treatment data from Part B of the MARCH Phase 2 study evaluating combinations of tobevibart and elebsiran, with or without pegylated interferon alfa (PEG-IFNα), in participants with&nbsp;<a target="_blank" href="https://www.benzinga.com/general/biotech/24/11/42016186/whats-going-on-with-liver-disease-focused-vir-biotechnology-stock-is-friday" rel="noreferrer noopener">chronic hepatitis B</a>.
Price Action: VIR stock is up 73.60% at $13.70 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/guidance/25/01/42872802/franchise-fallout-yum-terminates-turkey-deal-over-standards-issues-expects-pre-tax-special-charge" target="_blank" rel="noreferrer noopener">Franchise Fallout: Yum! Terminates Turkey Deal Over Standards Issues, Expects Pre-Tax Special Charge</a></li>
</ul>

Biotech

Movers

Trading Ideas

Vir Biotechnology Stock Soars On Prostate Cancer Trial Data - Here's Why

CIBC analyst Mark Jarvi maintains NextEra Energy Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEP#NYSE">NEP</a>) with a Neutral and lowers the price target from $26 to $21.

CIBC Maintains Neutral on NextEra Energy Partners, Lowers Price Target to $21

Live On CNBC, Trian Says Solventum Trades At A Discount To Its Peers And 3M Itself

Trading Halt: Halted at 12:25:07 p.m. ET - Trading Halt: Halt News Pending

On Wednesday, Boston Scientific Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) agreed to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for coronary and <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/n42869851/boston-scientific-announces-agreement-to-acquire-bolt-medical-inc" rel="noreferrer noopener">peripheral artery disease</a>.
Cholesterol deposits often create narrowed arteries and may also have a buildup of calcium that can increase the complexity of potential treatments. Lithotripsy is a procedure in which a physician breaks up hardened masses such as calcium to help restore blood flow.
The Bolt IVL system is designed to use lithotripsy to fracture calcium by creating acoustic pressure waves inside a balloon catheter.&nbsp;
Also Read: <a target="_blank" href="https://www.benzinga.com/24/12/42624916/boston-scientific-updates-instructions-for-cryoablation-balloons-after-reports-of-severe-injuries" rel="noreferrer noopener">Boston Scientific Updates Instructions for Cryoablation Balloons After Reports Of Severe Injuries</a>
The system also includes visible, directional emitters for consistent energy delivery in treating the calcified lesions.
Boston Scientific initially developed the concept for the Bolt IVL system, which helped establish Bolt Medical in 2019.
As a strategic investor in Bolt Medical, Boston Scientific has an equity stake of approximately 26%.
As a result, the transaction consists of an upfront payment of approximately&nbsp;$443 million&nbsp;for the 74% stake not yet owned and up to&nbsp;$221 million&nbsp;upon achievement of certain regulatory milestones.
On a 100% basis, before consideration of Boston Scientific&#8217;s current equity ownership in Bolt Medical, debt, and other closing adjustments, the transaction price consists of&nbsp;$600 million&nbsp;upfront and up to&nbsp;$300 million&nbsp;upon achievement of certain regulatory milestones.
Bolt Medical recently announced the completion and results of the RESTORE ATK and RESTORE BTK pivotal clinical trials investigating the Bolt IVL Above the Knee and Below the Knee systems for peripheral artery disease in patients with moderate to severely calcified lesions.
In&nbsp;December 2024, Bolt Medical received FDA approval to commence the global FRACTURE IDE clinical trial in the U.S., which is investigating the use of the Bolt IVL&#x2122; Coronary System for the treatment of coronary arterial disease with severely calcified lesions.
The deal is expected to be completed in the first half of 2025.
On an adjusted basis, the company expects the transaction to be slightly dilutive to adjusted EPS in 2025 and to offset via internal cost efficiencies and trade-offs. 
On a GAAP basis, the transaction is expected to be more dilutive due to amortization expense and acquisition-related charges, except for a one-time gain to be recognized at closing associated with the company&#8217;s previously held equity interest in Bolt Medical. 
Price Action: BSX stock is up 4.91% at $96.51 at the last check on Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/01/42877913/jasper-therapeutics-skin-disorder-candidate-data-fails-to-cheer-investors" target="_blank" rel="noreferrer noopener">Jasper Therapeutics Skin Disorder Candidate Data Fails To Cheer Investors</a></li>
</ul>
Photo via Shutterstock

Large Cap

Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal

Arcadium Lithium Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALTM#NYSE">ALTM</a>) shares are trading higher on Wednesday after the company announced that it secured Committee on Foreign Investment in&nbsp;the United States (CFIUS) <a href="https://www.benzinga.com//node/42871559">clearance</a> regarding Rio Tinto&#8216;s proposed acquisition.
The Details: Arcadium entered into a definitive agreement to be acquired by Rio Tinto in an all-cash transaction valued at $5.85 per share <a href="https://www.benzinga.com//node/41243501">back in October</a>. This represents a premium of 90% to Arcadium&#8217;s closing price of $3.08 per share on Oct. 4.
By acquiring Arcadium, Rio Tinto gains its Tier 1 assets with strong, consistent margins and a resource base projected to support 130% capacity growth by 2028 within Rio Tinto&#8217;s existing regions.
Furthermore, the companies have complementary footprints and extensive history in Argentina and Quebec, where Rio Tinto plans to establish world-class lithium hubs. By combining technological leadership in lithium extraction, the acquisition will position Rio Tinto as a market leader in lithium processing both in these regions and beyond.
Moreover, Rio Tinto is confident in the long-term outlook for lithium, anticipating a compound annual growth rate of over 10% in lithium demand through 2040, which is expected to result in a supply deficit.
&#8220;Acquiring Arcadium Lithium is a significant step forward in Rio Tinto&#8217;s long-term strategy, creating a world-class lithium business alongside our leading aluminum and copper operations to supply materials needed for the energy transition,&#8221; said Rio Tinto CEO Jakob Stausholm.
&#8220;Arcadium Lithium is an outstanding business today and we will bring our scale, development capabilities and financial strength to realize the full potential of its Tier 1 portfolio. This is a counter-cyclical expansion aligned with our disciplined capital allocation framework, increasing our exposure to a high-growth, attractive market at the right point in the cycle.&#8221;
See Also: <a href="https://www.benzinga.com/markets/equities/25/01/42879239/li-auto-achieves-200000-units-of-li-l6-suv-production-report">Li Auto Achieves 200,000 Units Of Li L6 SUV Production: Report</a>
ALTM Price Action: At the time of publication, Arcadium shares are moving 8.44% higher at $5.71, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: Courtesy of Arcadium Lithium Plc

ALTM

What's Going On With Arcadium Lithium Stock Wednesday?

MariMed Inc. (MRMD) Q2 2024 Earnings Call Transcript

MariMed (MRMD) has provided an update. MariMed Inc. has announced Mario Pinho as their new Chief Financial Officer effective August 9, 2024. With n...

MariMed Names Mario Pinho as New CFO, Enhancing Financial Leadership

American views on marijuana effects worsening: Gallup

MariMed (MRMD) announced the start of cannabis product manufacturing in Missouri. MariMed's award-winning products are expected to be available acr...

Marimed commences manufacturing operations in Missouri

InHouse, MariMed's (MRMD), is committed to serving local communities by finding ways to provide support to those in need. The mission continues thi...

Marimed's InHouse launches Help on the Homefront

Here are the major earnings after the close today

MariMed GAAP EPS of $0.00, revenue of $40.6M misses by $1.1M

MariMed Inc. (MRMD) Q3 2024 Earnings Call Transcript

Marimed ( ($MRMD) ) has released its Q3 earnings. Here is a breakdown of the information Marimed presented to its investors. MariMed Inc. is a lead...

MariMed Inc. Reports Third Quarter 2024 Earnings

MariMed (MRMD) announces the launch of cannabis wholesale operations in Missouri. MariMed's products are now available in select dispensaries acros...

Marimed commences wholesale operations in Missouri

AAWH

ACAD

ACLS

ADTN

AEVA

ALTO

AMPH

AMPY

AMRK

ANSS

APPS

ARAY

ARQT

ASPN

AYRWF

BBDC

BIRD

CNBS

CRLBF

CRON

CURLF

CWBHF

DUOL

ENLC

ETRGF

FLGC

GLASF

GPMT

GTBIF

HCAT

HITI

HRTG

HUBS

IIPR

IONQ

JAZZ

JOBY

JUSHF

KNTK

LAND

LILA

LILAK

LOPE

LUNMF

LYFT

MAPS

MATV

MEOH

MKSI

MRMD

MTCH

NDLS

NEWT

NMIH

NVGS

PCLOF

PLNH

SNDL

TCNNF

TLRY

VRNOF

YCBD

YOLO

Press Releases

MariMed's Bubby's Baked Introduces New, Limited-Edition Pumpkin Bread Bites This Autumn

MariMed Commences Adult-Use Sales at Thrive Wellness Dispensary in Tiffin, Ohio

MariMed's Betty's Eddies Partners With Keep A Breast Foundation to Promote Breast Cancer Screening Education

MariMed's Nature's Heritage Gives Local Musicians a Chance to be Featured in New Interactive Vape Campaign

MariMed Announces Third Quarter 2024 Earnings Date

MariMed Commences Cultivation Operations in Mt. Vernon, Illinois Grow Facility

MariMed Commences Manufacturing Operations in Missouri

InHouse by MariMed Launches Help on the Homefront, to Support Veterans Facing Housing Challenges

Comments

MariMed

Intérêt court

MariMed (OTC:MRMD) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL